Stockreport

Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combined with Limited Chemotherapy in First-Line Lung Cancer

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF FDA application granted Priority Review designation with PDUFA date of August 6, 2020Submissions based on results from Phase 3 CheckMate -9LA trial PRINCETON, N.J.--( [Read more]